1244089

Naval Daver, M.D. — FEI 3030821517

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)